Updated 07:15 GMT, 18 Nov 2026 SPX 7,340.53 -1.03% NDX 27,001.78 -0.72% VIX 25.46 +11.13% GOLD 3,772.20 -2.38% CL 83.98 -2.36% BTC 64,721.99 -0.26%
NAS100 27,002 −0.72% S&P 7,341 −1.03% GOLD $3,772 −2.38% BTC $64,722 −0.26% VIX 25.46 +11.13% latest tape · as of 07:15 UTC
The Screen · Consumer Defensive · Beverages - Non-Alcoholic

Coca-Cola Company (The) logoCoca-Cola Company (The)

KO · a US exchange · USD · Market cap $413.1B · 65,900 employees

The Coca-Cola Company, a beverage company, manufactures and sells various nonalcoholic beverages in the United States and internationally.

FAIL · Does not pass the screen
98.79 USD

Price as of 17 Nov 2026Daily close, not a live quote

Screened 2026-11-17 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price98.79 USD at the 17 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 17 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.69)
  • Last reviewed17 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $72.00 to $84.24, base estimate $73.25 (screen dated 2026-11-17).

Current read
Markup ?
Overvalued · screened 2026-11-17
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning political buying, disclosed 2026-10-01
  • Options put/call open interest 0.69, read 2026-11-13
  • Ethical does not pass the values gate
Price98.79 USD
Fair value73.25
Ethical score10.0/100
Value readOvervaluedas of 17 Nov 2026
Our investment reviews on this name
2026-10-18Read Markup91.78+7.6% to today ✓Accumulation gives way to Markup first Markup read since August
2026-10-11Read Accumulation87.81+12.5% to today ✓Markdown gives way to Accumulation
2026-10-02Read Markdown87.81+12.5% to today Markup gives way to Markdown after a 10% rise in 13 weeks
2026-07-02Read Markup79.48+24.3% to today ✓First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Coca-Cola Company (The) holds its Markup at $98.79. Consolidating, no directional conviction, held for 10 days.

As held on the ledger · 2026-11-17
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 10 days
Price at the screen$98.79
Valuation28.33 trailing · 27.22 forward price to earnings
Values screenFAIL · score 10.0
Beta0.27
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 43.40% Below 33% Interest-bearing debt is 43.4% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 19.31% Below 33% Cash held in interest-bearing accounts and securities is 19.3% of assets, under the one-third limit. Pass
Receivables 12.70% Below 49% Money owed to the company is 12.7% of assets, under the 49% limit. Pass
Revenue purity 1.64% Below 5% Only 1.6% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Coca-Cola Company (The)'s business is in a permissible area, but its interest-bearing debt is about 43% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when KO's ethical verdict changes

Today KO does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 17 Nov 2026: it trades above our $73.25 fair value estimate, strong competitive moat, 7.40% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

72.00Conservative73.25Base case84.24Growth case 98.79Price

Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. The price runs 34.9% above the base estimate.

The Street's Range
80.00Street low 100.00Street average 106.00Street high 98.79Price

Third-party analyst targets: 24 covering, consensus Buy. The average target sits +1% from the screen price.

Reading the gap · Both our model and the Street see limited upside at this price.

Price History & Projections

Where our models see it going: fair-value estimate $73.25, with a range of $72.00 to $84.24, dated to the 2026-11-17 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At 27.2x forward earnings, the price already runs ahead of the business. It trades 35% above our $73.25 fair value, so you would be buying at a premium, not a discount. The strong moat is real, but quality alone does not make an expensive price cheap.

The fundamentals · plain-English read
Forward P/E27.2xexpensive even after accounting for its growth
Trailing P/E28.3xa premium valuation
EPS, trailing3.39
EPS, forward3.53
Revenue growth+7.4%slow but positive growth
Profit margin28.7%healthy profit margins
Return on equity40.6%an exceptional return on shareholder capital
FCF yield1.05%
Dividend yield2.60%
Debt to equity1.07a meaningful debt load worth watching
Current ratio1.38adequate liquidity, worth monitoring
Beta0.27barely tracks the market's swings
Short interest, float0.01%
52-week range67.27 - 97.39
MoatSTRONG
Market cap$413.1B
Employees65,900

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

KO trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-17 Markup $99.25 +3.4% Entry 23

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 19%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (23 analysts) rates it buy, with a mean price target of $86.

2026-11-10 Markup $96.03 +2.1% Entry 22

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 19%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (23 analysts) rates it buy, with a mean price target of $86.

2026-11-03 Markup $94.08 +2.5% Entry 21

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 19%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (23 analysts) rates it buy, with a mean price target of $86.

2026-10-27 Markup $91.78 +0.0% Entry 20

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 19%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (23 analysts) rates it buy, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Markup $91.78 +0.0% Entry 19

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 19%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (23 analysts) rates it buy, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Markup $91.78 +0.0% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 19%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (23 analysts) rates it buy, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Markup $91.78 +0.0% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 19%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (23 analysts) rates it buy, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Markup $91.78 +0.0% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 19%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (23 analysts) rates it buy, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-22 Markup $91.78 +0.0% Entry 15

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 19%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (23 analysts) rates it buy, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-21 Markup $91.78 +0.0% Entry 14

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 19%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (23 analysts) rates it buy, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on KO

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in KO's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · KO
DateInsiderTitleTypeSharesValue
2026-05-15 QUAN NANCY W Officer 31,625 $2,559,519
2026-05-15 QUAN NANCY W Officer 31,625 $1,436,882
2026-05-11 QUINCEY JAMES R. Chairman of the Board 44,678 ·
2026-05-07 QUINCEY JAMES R. Chairman of the Board 200,000 $15,780,900
2026-03-09 DOUGLAS MONICA HOWARD Officer 23,880 $1,847,686
2026-03-03 QUINCEY JAMES R. Chief Executive Officer 250,688 $19,839,138
2026-03-03 PIETRACCI BRUNO Divisional Officer 28,765 $2,284,318
2026-03-03 QUAN NANCY W Officer 23,556 $1,872,747
2026-03-02 MURPHY JOHN President 72,449 $5,833,934
2026-02-27 PEREZ BEATRIZ R Officer 21,326 $1,727,406

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming KO
DatePoliticianPartyTypeAmount
2026-10-15 Josh Gottheimer Democrat sell 1K–15K
2026-10-15 Josh Gottheimer Democrat sell 1K–15K
2026-10-01 Lloyd Doggett Democrat buy 1K–15K
2026-09-15 Kevin Hern Republican buy 15K–50K
2026-09-15 Kevin Hern Republican buy 15K–50K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $78.66 +6.4% · $1,064 +6.4%
2 months $77.47 +8.0% · $1,080 +8.0%
3 months $77.08 +8.5% $0.53 $1,092 +9.2%
6 months $68.64 +21.9% $0.53 $1,227 +22.7%
1 year $70.31 +19.0% $2.06 $1,219 +21.9%
2 years $60.00 +39.4% $4.03 $1,461 +46.1%
3 years $55.30 +51.3% $5.89 $1,620 +62.0%
5 years $48.39 +72.9% $9.37 $1,923 +92.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever KO does next, these words stay.

Coca-Cola Company (The) · KO · Markup · $98.79
Recorded 2026-11-17 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.